Volume 11, Number 10—October 2005
Letter
Melioidosis in Tsunami Survivors
Table
Patient no. | Age (y)/sex | Radiograph results | Complications | Microbiologic test results | Days before treatment | Antimicrobial drug | Acute outcome |
---|---|---|---|---|---|---|---|
1 | 7/M | Bilateral infiltrates | Cavitation | No cultures taken | 19 | Meropenem | Fever resolved, improving @30 days |
2 | 12/M | Bilateral infiltrates | Pseudomonas aeruginosa (sputum) | 37 | Meropenem | Serious but stable @12 days | |
3 | 5/M | Unilateral infiltrates | Cavitation | No cultures taken | 10 | Meropenem | Fever resolved, improving @39 days |
4 | 15/F | Bilateral infiltrates | Pneumothorax, empyema | Burkholderia pseudomallei (sputum) | 27 | Meropenem 2 wks, then oral TMP-SMX and coamoxiclav | Fully recovered, discharged @20 days |
5 | 14/M | Bilateral infiltrates | P. aeruginosa (sputum) | 35 | Meropenem | Improving @11 days | |
6 | 6/M | Bilateral infiltrates | P. aeruginosa (sputum) | 30 | Meropenem | Improving @19 days | |
7 | 18 mo/M | Bilateral infiltrates | Empyema | B. pseudomallei (pleural fluid) | 30 | Meropenem | Improving @23 days |
8 | 10/F | Bilateral infiltrates | Empyema | P. aeruginosa B. pseudomallei Klebsiella sp. (pleural fluid) | 30 | Meropenem | Improving @23 days |
9 | 13/F | Bilateral infiltrates | P. aeruginosa B. pseudomallei (sputum) | 33 | Meropenem | Improving @18 days | |
10 | 17/F | Unknown | Unknown | Nocardia spp. (sputum) | 21 | Ticarcillin/clavulanate, ciprofloxacin | Not improving, outcome unknown @12 days |
*ICU, intensive care unit; TMP-SMX, trimethoprim-sulfamethoxazole.
Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.